Sat.Oct 03, 2020 - Fri.Oct 09, 2020

article thumbnail

Pharma’s digital transformation journey and the role of customer reference data

pharmaphorum

Better management of customer data could help pharmaceutical companies’ digital transformation, according to Veeva’s Rebecca Silver. pharmaphorum’s Richard Staines spoke to her about how the use of customer reference data can transform pharma companies, increase competitiveness, and benefit the bottom line during these challenging times. Precision medicine is emerging as a key approach for disease treatment and prevention, which makes it even more critical to get the right medicine to the

article thumbnail

Clinical trials have ‘much work to do’ in boosting diversity

Outsourcing Pharma

A veteran with more than 20 years of experience talks about the vitality of recruiting an inclusive patient population, and the perils of falling short.

134
134
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Trump’s Covid Treatments Were Tested in Cells Derived From Fetal Tissue

NY Times

The “cell lines” used to develop monoclonal antibodies, as well as remdesivir and vaccines, began with fetal tissue decades ago.

Vaccines 126
article thumbnail

Finding and Evaluating Generic Drug Market Entry Opportunities

Drug Patent Watch

Here is a copy of the talk I gave at the recent Marcusevans 13th Portfolio Management and Pipeline Optimization for Generics. I cover: How to find and evaluate generic entry…. The post Finding and Evaluating Generic Drug Market Entry Opportunities appeared first on DrugPatentWatch - Make Better Decisions.

102
102
article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

article thumbnail

Excel spreadsheet blamed for UK’s COVID-19 test and trace woes

pharmaphorum

An Excel spreadsheet was behind IT glitch that caused thousands of positive COVID-19 tests to be omitted from the UK’s official records, according to press reports. The issue that left almost 16,000 positive results going unreported has been blamed on the way Public Health England tracks results from mainly private labs that have been hired to add extra testing capacity.

Hospitals 128
article thumbnail

Perspectives on a Post-pandemic World

Pharma Marketing Network

An interview with Mark Bard, Co-Founder of The DHC Group and Justin Grossman, CEO/Managing Partner, meltmedia. In response to this week’s DHC Virtual Summit with Novartis, Mark Bard, Co-founder/Managing Partner, DHC, talked one-on-one with Justin Grossman about how the COVID pandemic will change the world of digital healthcare marketing. Here are some highlights from their discussion.

More Trending

article thumbnail

ABPI calls on UK government to create non-COVID clinical research strategy

Pharma Times

New report finds UK is leading on early-stage clinical trials but needs strategy to restart non-COVID research

119
119
article thumbnail

Your.MD secures $30m to expand self-care app Healthily

pharmaphorum

Digital health firm Your.MD has secured $30 million in a Series A round investment led by the consumer health giant Reckitt Benckiser (RB). Your.MD is the company behind the medical-grade, augmented intelligence self-care app Healthily, and will use the funding to accelerate the platform through a series of clinically-validated “health hubs”. Following a seed funding round led by RB and existing shareholders, the now completed Series A funding round will allow the app to reach other markets incl

124
124
article thumbnail

Perspectives on a Post-pandemic World

Pharma Marketing Network

An interview with Mark Bard, Co-Founder of The DHC Group and Justin Grossman, CEO/Managing Partner, meltmedia. In response to this week’s DHC Virtual Summit with Novartis, Mark Bard, Co-founder/Managing Partner, DHC, talked one-on-one with Justin Grossman about how the COVID pandemic will change the world of digital healthcare marketing. Here are some highlights from their discussion.

article thumbnail

New patent expiration for Leo Labs drug PICATO

Drug Patent Watch

Annual Drug Patent Expirations for PICATO Picato is a drug marketed by Leo Labs and is included in one NDA. It is available from one supplier. There are thirteen patents…. The post New patent expiration for Leo Labs drug PICATO appeared first on DrugPatentWatch - Make Better Decisions.

97
article thumbnail

Why Every Small Business Needs an HCM Solution: A Comprehensive Guide

Managing HR tasks like payroll, compliance, and employee data can overwhelm small businesses. That’s where a Human Capital Management (HCM) solution comes in. Our eBook, Why Every Small Business Needs an HCM Solution: A Comprehensive Guide , shows how an HCM system automates tedious processes, ensuring your business stays compliant and efficient. You’ll learn how to simplify payroll, eliminate costly errors, and empower your employees with self-service tools.

article thumbnail

BMS’ Opdivo plus Yervoy misses the mark in high-risk melanoma

Pharma Times

Combination treatment did not achieve statistical significance in all-comer population

130
130
article thumbnail

Axovant pushes on with Parkinson’s gene therapy, despite investor cynicism

pharmaphorum

Axovant has said it plans to continue developing its Parkinson’s Disease gene therapy after reporting supportive data from a small cohort of patients from a phase 2 trial. However shares in Axovant were down sharply after the announcement because of market sentiment that the New York biotech had been selective with the data it had shared in its update.

119
119
article thumbnail

Premier Research: holistic approach benefits drug development

Outsourcing Pharma

A leader from the CRO shares insights as to what strategies and philosophies work best when working to craft a successful drug development program.

article thumbnail

Maintaining Both Your Business and Your Sanity During the Pandemic

Pharma Marketing Network

Just a little more than seven months ago, pharma, agencies, vendors, physicians, pharmacists, patients, and medical supply chains in the U.S. and across the world were caught in a whirlwind of groundlessness and anxiety as Covid -19’s spread quickly enveloped much of the planet. Such a shock to the system required a lot of intense, focused learning to keep the industry up and running, to keep all of healthcare’s stakeholders connected, to continue the mission to safeguard and preserve health.

article thumbnail

Best Practices to Streamline Compensation Management: A Foundation for Growth

Speaker: Joe Sharpe and James Carlson

Payroll optimization can be one of the most time-consuming and complex factors of small business management. Yet, organizations that crack the code on streamlining employee compensation often discover innovative avenues for growth. With the right strategies in place, outsourcing and streamlining payroll processes can result in substantial time and resource savings.

article thumbnail

ViiV’s two-drug HIV regimen demonstrates long-term efficacy

Pharma Times

Two-drug regimen continues to offer non-inferior efficacy compared to a three-drug regimen

122
122
article thumbnail

Pharma’s response to COVID: GSK

pharmaphorum

A few months into the pandemic, the world is now moving beyond managing the crisis, with more focus on addressing the collateral damages and shaping the future. As part of a new series looking at how pharma has responded to the pandemic, Neale Belson, SVP UK & Ireland and general manager for the UK at GSK, tells us that it is “absolutely critical” to do this with the pace and out-of-the box thinking of the past months.

Vaccines 111
article thumbnail

People on the Move: October 2020

Outsourcing Pharma

The latest news on pharmaceutical industry hires, promotions, acquititions and other events includes Medable, Eversana, Parexel, Astellas and more.

98
article thumbnail

Trump’s Covid Treatments Suggest a Serious Condition

NY Times

Outside experts pointed to the therapies as signs that the president’s health may not be as good as his doctors said. His age, weight and gender put him at high risk.

81
article thumbnail

Position Your Pharmacy for Expansion

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

article thumbnail

Gilead inks supply agreement with the European Commission for remdesivir

Pharma Times

New agreement allows countries in the EU, EEA and the UK to purchase drug

130
130
article thumbnail

Older people first to receive COVID-19 vaccine in UK, says government

pharmaphorum

As European regulators begin a rolling review of AstraZeneca’s COVID-19 vaccine, the focus in the UK has shifted to the government’s plans to distribute any vaccine that is deemed to be a safe and effective way of preventing the disease. According to weekend press reports a rollout of a vaccine could be just three months away – but the feedback from the government is that not everyone will get it, with the target group being around 30 million older people and health workers, less than half the p

Vaccines 111
article thumbnail

Clinical trial volume, variety drive data solutions

Outsourcing Pharma

eClinical, a provider of clinical data service solutions, has seen an increase in interest in clinical data platform and other digital products.

85
article thumbnail

Clinical Trials Hit by Ransomware Attack on Health Tech Firm

NY Times

No patients were affected, but the incident was another reminder of the risks in the increasingly common assaults on computer networks.

81
article thumbnail

Enhance Healthcare Efficiency With Top Payroll & HCM Services

Running a healthcare facility requires precision and care, not just for patients but also for your staff. Our guide, "A Buyer’s Guide to Payroll & HCM Services," helps healthcare providers choose the best provider. Efficient payroll management ensures timely, accurate payments, critical for maintaining staff morale and trust. Compliance support helps navigate complex healthcare regulations and avoid costly fines.

article thumbnail

EMA accepts filing for Biogen/Samsung Bioepis’ Lucentis biosimilar

Pharma Times

Biosimilar is an anti-VEGF therapy for retinal vascular disorders

article thumbnail

Eli Lilly and Gilead’s combination cuts COVID-19 recovery time

pharmaphorum

Eli Lilly’s Olumiant (baricitinib) has a significant effect on recovery from COVID-19 when combined with Gilead Veklury (remdesivir), according to a large trial backed by funding from the US government. The findings came from additional safety and efficacy data harvested from the US National Institute of Allergy and Infectious Diseases’ (NIAID) ACCT-2 trial.

article thumbnail

Investors bet on decentralized trial technology

Outsourcing Pharma

Companies like Biofourmis, THREAD and other virtual tech specialists have seen infusions of funds from investors bullish on decentralized clinical trials.

72
article thumbnail

How is Cell Isolation Revolutionizing Medical Industry?

Pharma Mirror

One of the biggest medical advancements of recent times is the invention of the cell isolation method. Also known as cell sorting or cell separation, the cell isolation method has rapidly become an integral component of modern biological and medical research. In this method, a one-cell population or multiple cell types are isolated from a. The post How is Cell Isolation Revolutionizing Medical Industry?

64
article thumbnail

5 Reasons to Upgrade Your Pharmacy Management Software

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

article thumbnail

Neuroblastoma UK welcomes advancement of potential new treatment

Pharma Times

Fadraciclib has passed safety trials and shown early efficacy

129
129
article thumbnail

Flying the flag for research in Aarskog syndrome

pharmaphorum

Delayed diagnosis, lack of awareness, and a limited evidence base – Aarskog syndrome faces all the challenges of rare diseases everywhere. But a new study hopes to kick start a revolution in understanding. For five years, Michelle Erskine faced a succession of closed doors and disbelief as she struggled to convince someone that all was not well with her son.

110
110
article thumbnail

Against Covid-19, Imperfect Measures Do the Most Good

NY Times

Speed and scale may matter more than absolute effectiveness when it comes to tests, masks, treatments and vaccines.

article thumbnail

Which pharmaceutical companies have the largest patent portfolios?

Drug Patent Watch

A strong patent portfolio is at the core of branded pharmaceutical firms. Accordingly, one way to assess the relative strength of pharmaceutical firms is to compare their patent-counts. This chart…. The post Which pharmaceutical companies have the largest patent portfolios? appeared first on DrugPatentWatch - Make Better Decisions.

article thumbnail

Merck KGaA out-licenses osteoarthritis programme to Novartis

Pharma Times

Potential disease modifying osteoarthritis candidate is phase II ready

122
122